Immunoliposomes Doubly Targeted to Transferrin Receptor and to α-Synuclein

Abstract

Immunoliposomes targeted to BBB receptors and to α-synuclein could potentially enable the transport of drugs across the BBB and reach one of the drug targets in Parkinson's disease.